Cargando…

Molecular Profiling in Resectable Colorectal Liver Metastases: The Role of KRAS Mutation Status in Assessing Prognosis in the Preoperative Setting

Detalles Bibliográficos
Autor principal:	Coulson, Ryanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Harborside Press 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803464/ https://www.ncbi.nlm.nih.gov/pubmed/27069739

Ejemplares similares

The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: a retrospective analysis
por: Kim, Hae Su, et al.
Publicado: (2016)

Is Laterality Prognostic in Resected KRAS-Mutated Colorectal Liver Metastases? A Systematic Review and Meta-Analysis
por: Belias, Michail, et al.
Publicado: (2022)

The Level of Preoperative Plasma KRAS Mutations and CEA Predict Survival of Patients Undergoing Surgery for Colorectal Cancer Liver Metastases
por: Polivka, Jiri, et al.
Publicado: (2020)

Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection
por: Ardito, Francesco, et al.
Publicado: (2021)

Differential effects of KRAS mutational status on long-term survival according to the timing of colorectal liver metastases
por: Sakai, Nozomu, et al.
Publicado: (2021)

Efficacy of laparoscopic liver resection in colorectal liver metastases and the influence of preoperative chemotherapy
por: Kubota, Yoshihisa, et al.
Publicado: (2014)

Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases
por: Løes, Inger Marie, et al.
Publicado: (2016)

Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study
por: Uutela, Aki, et al.
Publicado: (2022)

Can the presence of KRAS mutations guide the type of liver resection during simultaneous resection of colorectal liver metastasis?
por: Choi, Munseok, et al.
Publicado: (2022)

Effect of KRAS and NRAS mutations on the prognosis of patients with synchronous metastatic colorectal cancer presenting with liver-only and lung-only metastases
por: Chuang, Shih-Chang, et al.
Publicado: (2020)

The Impact of KRAS Status on the Required Surgical Margin Width for Colorectal Liver Metastasis Resection
por: Iwaki, Kentaro, et al.
Publicado: (2023)

KRAS A146 Mutations Are Associated With Distinct Clinical Behavior in Patients With Colorectal Liver Metastases
por: van 't Erve, Iris, et al.
Publicado: (2021)

The Prognostic Significance of the Preoperative Full Blood Count after Resection of Colorectal Liver Metastases
por: Dajani, K., et al.
Publicado: (2009)

Preoperative Inflammatory Markers in Liver Resection for Colorectal Liver Metastases: A National Registry-Based Study
por: Sahakyan, Mushegh A., et al.
Publicado: (2023)

Significance of poor performance status after resection of colorectal liver metastases
por: Strandberg Holka, Peter, et al.
Publicado: (2018)

Borderline resectable for colorectal liver metastases: Present status and future perspective
por: Kitano, Yuki, et al.
Publicado: (2021)

KRAS mutation in colorectal cancer metastases after adjuvant FOLFOX for the primary
por: Vauthey, J-N, et al.
Publicado: (2012)

KRAS mutation in lung metastases from colorectal cancer: prognostic implications
por: Ghidini, Michele, et al.
Publicado: (2015)

KRAS mutation effects on the 2-[18F]FDG PET uptake of colorectal adenocarcinoma metastases in the liver
por: Popovic, M., et al.
Publicado: (2020)

Liver resection for non-colorectal metastases
por: Schwarz, Christoph, et al.
Publicado: (2018)

The Role of Preoperative Chemotherapy in the Management of Synchronous Resectable Colorectal Liver Metastases: A Meta-Analysis
por: Tepelenis, Kostas, et al.
Publicado: (2023)

KRAS Mutational Regression Is Associated With Oligo-Metastatic Status and Good Prognosis in Metastatic Colorectal Cancer
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

The Impact of KRAS Mutational Status on Long-Term Survival following Liver Resection for Hilar Cholangiocarcinoma
por: Ardito, Francesco, et al.
Publicado: (2022)

Resection after preoperative chemotherapy versus synchronous liver resection of colorectal cancer liver metastases: A propensity score matching analysis
por: Kim, Chan W., et al.
Publicado: (2017)

Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases
por: Shady, Waleed, et al.
Publicado: (2017)

Reply: KRAS mutation in colorectal cancer metastases after adjuvant folfox for the primary
por: Yoshino, T, et al.
Publicado: (2012)

Multiple Laparoscopic Liver Resection for Colorectal Liver Metastases
por: Nassar, Alexandra, et al.
Publicado: (2023)

Liver transplantation for non-resectable colorectal liver metastases
por: Aziz, Hassan, et al.
Publicado: (2023)

KRAS Assessment Following ESMO Recommendations for Colorectal Liver Metastases. Is It Always Worth It?
por: Morató, Olga, et al.
Publicado: (2022)

Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases
por: Lauko, Adam, et al.
Publicado: (2021)

The role of kras mutations and MSI status in diagnosis of colorectal cancer
por: Shemirani, Atena Irani, et al.
Publicado: (2011)

Somatic mutation profiling and HER2 status in KRAS-positive Chinese colorectal cancer patients
por: Dong, Zhouhuan, et al.
Publicado: (2019)

Coexistence of MSI with KRAS mutation is associated with worse prognosis in colorectal cancer
por: Hu, Jing, et al.
Publicado: (2016)

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients
por: Knijn, N, et al.
Publicado: (2011)

Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by (18)F-FDG-PET is associated with the KRAS mutation status and prognosis
por: Ikeno, Yoshinobu, et al.
Publicado: (2018)

Pathologic response after preoperative therapy predicts prognosis of Chinese colorectal cancer patients with liver metastases
por: Wang, Yun, et al.
Publicado: (2017)

More Liver Metastases Detected Intraoperatively Indicates Worse Prognosis for Colorectal Liver Metastases Patients after Resection Combined with Microwave Ablation
por: Jiang, Ling-Min, et al.
Publicado: (2022)

Prognostic Value of KRAS Gene Mutation on Survival of Patients with Peritoneal Metastases of Colorectal Adenocarcinoma
por: Díez-Alonso, Manuel, et al.
Publicado: (2021)

C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases
por: Wong, V K H, et al.
Publicado: (2007)

Prognosis of resectable colorectal liver metastases after surgery associated with pathological features of primary tumor
por: Chen, Dawei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kad2i340uohadt0ftfqdu6iu40